JB Pharma outlines key ESG goals & targets in Third Sustainability Report FY24
JB’s absolute Scope1 & Scope2 emissions reduced by 13.9 % in the last financial year, despite turnover increasing by 11%
JB’s absolute Scope1 & Scope2 emissions reduced by 13.9 % in the last financial year, despite turnover increasing by 11%
The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Good momentum in commercial CDMO business
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Subscribe To Our Newsletter & Stay Updated